Microparticles, thrombosis and cancer

Best Practice and Research: Clinical Haematology

Volumn 22, Issue 1, 2009, Pages 61-69

  Aharon, Anat ^a   Brenner, Benjamin ^b  

^a Thrombosis and Haemostasis Unit Department of Haematology and Bone Marrow Transplantation   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

angiogenesis; cancer; microparticles; microvesicles; thrombosis; tissue factor

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7A; CD61 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; FAS ANTIGEN; FAS LIGAND; FIBRIN; FIBRINOGEN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PADGEM PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

APOPTOSIS; BONE CANCER; BRAIN CANCER; BREAST CARCINOMA; COLORECTAL CANCER; DISEASE ASSOCIATION; ENDOTHELIAL MICROPARTICLE; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; INFLAMMATION; LIVER CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALIGNANT TRANSFORMATION; MEMBRANE MICROPARTICLE; NEOPLASM; NONHUMAN; PLATELET MICROPARTICLE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; THROMBOGENESIS; THROMBOGENICITY; THROMBOSIS; TUMOR GROWTH; TUMOR VASCULARIZATION;

APOPTOSIS; BLOOD COAGULATION FACTORS; CELL-DERIVED MICROPARTICLES; HUMANS; NEOPLASMS; THROMBOSIS;

EID: 61649125397     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beha.2008.11.002     Document Type: Review

References (68)

1. Février B., and Raposo G. Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol 16 (2004) 415-421
2. Simak J., and Gelderman M.P. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 20 (2006) 1-26
3. Essayagh S., Xuereb J.M., Terrisse A.D., et al. Microparticles from apoptotic monocytes induce transient platelet recruitment and tissue factor expression by cultured human vascular endothelial cells via a redox-sensitive mechanism. Thromb Haemost 98 (2007) 831-837
4. Mack M., Kleinschmidt A., Brühl H., et al. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med 6 (2000) 769-775
5. Baj-Krzyworzeka M., Szatanek R., Weglarczyk K., et al. Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol Immunother 55 (2006) 808-818
6. Furie B., and Furie B.C. Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation. Trends Mol Med 10 (2004) 171-178
7. Lynch S.F., and Ludlam C.A. Plasma microparticles and vascular disorders. Br J Haematol 137 (2007) 36-48
8. Pihusch R., Höhnberg B., Salat C., et al. Platelet flow cytometric findings in patients undergoing conditioning therapy for allogeneic hematopoietic stem cell transplantation. Ann Hematol 81 (2002) 454-461
9. Ratajczak J., Wysoczynski M., Hayek F., et al. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 20 (2006) 1487-1495
10. Piccin A., Murphy W.G., and Smith O.P. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 21 (2007) 157-171
11. Lechner D., and Weltermann A. Chemotherapy-induced thrombosis: a role for microparticles and tissue factor?. Semin Thromb Hemost 34 (2008) 199-203
12. Otten H.M., Mathijssen J., ten Cate H., et al. Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon. Arch Intern Med 164 (2004) 190-194
13. Trujillo-Santos J., Nieto J.A., Tiberio G., et al. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost 100 (2008) 435-439
14. Kwon H.M., Kang B.S., and Yoon B.W. Stroke as the first manifestation of concealed cancer. J Neurol Sci 258 (2007) 80-83
15. Rak J., Yu J.L., Luyendyk J., et al. Oncogenes, Trousseau syndrome, and cancer-related changes in the coagulome of mice and humans. Cancer Res 66 (2006) 10643-10646
16. Taccone F.S., Jeangette S.M., and Blecic S.A. First-ever stroke as initial presentation of systemic cancer. J Stroke Cerebrovasc Dis 17 (2008) 169-174
17. Sørensen H.T., Mellemkjaer L., Steffensen F.H., et al. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 338 (1998) 1169-1173
18. Chou J., Mackman N., Merrill-Skoloff G., et al. Hematopoietic cell-derived microparticle tissue factor contributes to fibrin formation during thrombus propagation. Blood 104 (2004) 3190-3197
19. Ueno T., Toi M., Koike M., et al. Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration. Br J Cancer 83 (2000) 164-170
20. López J.A., del Conde I., and Shrimpton C.N. Receptors, rafts, and microvesicles in thrombosis and inflammation. J Thromb Haemost 3 (2005) 1737-1744
21. Diamant M., Tushuizen M.E., Sturk A., et al. Cellular microparticles: new players in the field of vascular disease?. Eur J Clin Invest 34 (2004) 392-401
22. Del Conde I, Shrimpton CN, Thiagarajan P, et al. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. Blood 106 (2005) 1604-1611
23. Furie B., and Furie B.C. Mechanisms of thrombus formation. N Engl J Med 359 (2008) 938-949
24. Martinez M.C., Tesse A., Zobairi F., et al. Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am J Physiol Heart Circ Physiol 288 (2005) H1004-H1009
25. Aharon A., Tamari T., and Brenner B. Monocyte derived microparticles and exosomes induce procoagulant and apoptotic effects on endothelial cells. Thromb Haemost 100 (2008) 878-885
26. Rauch U., Bonderman D., Bohrmann B., et al. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood 96 (2000) 170-175
27. Tesselaar M.E., and Osanto S. Risk of venous thromboembolism in lung cancer. Curr Opin Pulm Med 13 (2007) 362-367
28. Davila M., Amirkhosravi A., Coll E., et al. Tissue factor-bearing microparticles derived from tumor cells: impact on coagulation activation. J Thromb Haemost 6 (2008) 1517-1524
29. Yu J.L., and Rak J.W. Shedding of tissue factor (TF)-containing microparticles rather than alternatively spliced TF is the main source of TF activity released form human cancer cells. J Thromb Haemost 2 (2004) 2065-2067
30. Nieuwland R. Cellular origin of microparticles exposing tissue factor in cancer: a mixed double?. J Thromb Haemost 6 (2008) 1514-1516
31. Zwicker J.I. Tissue factor-bearing microparticles and cancer. Semin Thromb Hemost 34 (2008) 195-198
32. Hron G., Kollars M., Weber H., et al. Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer. Thromb Haemost 97 (2007) 119-123
33. Tesselaar M.E., Romijn F.P., Van Der Linden I.K., et al. Microparticle-associated tissue factor activity: a link between cancer and thrombosis?. J Thromb Haemost 5 (2007) 520-527
34. Kanazawa S., Nomura S., Kuwana M., et al. Monocyte-derived microparticles may be a sign of vascular complication in patients with lung cancer. Lung Cancer 39 (2003) 145-149
35. Tilley R.E., Holscher T., Belani R., et al. Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients. Thromb Res 122 (2008) 604-609
36. Langer F., Spath B., Haubold K., et al. Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation. Ann Hematol 87 (2008) 451-457
37. Regina S., Rollin J., Bléchet C., et al. Tissue factor expression in non-small cell lung cancer: relationship with vascular endothelial growth factor expression, microvascular density, and K-ras mutation. J Thorac Oncol 3 (2008) 689-697
38. Yu J., May L., Milsom C., et al. Contribution of host-derived tissue factor to tumor neovascularization. Arterioscler Thromb Vasc Biol 28 (2008) 1975-1981
39. Mesri M., and Altieri D.C. Endothelial cell activation by leukocyte microparticles. J Immunol 161 (1998) 4382-4387
40. Mesri M., and Altieri D.C. Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway. J Biol Chem 274 (1999) 23111-23118
41. Huber L.C., Jungel A., Distler J.H., et al. The role of membrane lipids in the induction of macrophage apoptosis by microparticles. Apoptosis 12 (2007) 363-374
42. Bombeli T., Karsan A., Tait J.F., et al. Apoptotic vascular endothelial cells become procoagulant. Blood 89 (1997) 2429-2442
43. Abrahams V.M., Straszewski-Chavez1 S.L., Guller S., et al. First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis. Mol Hum Reprod 10 (2004) 55-63
44. Monleón I., Martínez-Lorenzo M.J., Monteagudo L., et al. Differential secretion of Fas ligand- or APO2 ligand/TNF-related apoptosis-inducing ligand-carrying microvesicles during activation-induced death of human T cells. J Immunol 167 (2001) 6736-6744
45. Kim J.W., Wieckowski E., Taylor D.D., et al. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clin Cancer Res 11 (2005) 1010-1020
46. Huber V., Fais S., Iero M., et al. Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape. Gastroenterology 128 (2005) 1796-1804
47. Andreola G., Rivoltini L., Castelli C., et al. Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles. J Exp Med 195 (2002) 1303-1316
48. Prado-Garcia H., Aguilar-Cazares D., Meneses-Flores M., et al. Lung carcinomas do not induce T-cell apoptosis via the Fas/Fas ligand pathway but down-regulate CD3 epsilon expression. Cancer Immunol Immunother 57 (2008) 325-336
49. Bohana-Kashtan O., and Civin C.I. Profiling tumor counterattack: do Fas ligand-containing microvesicles reduce anticancer immunity?. Clin Cancer Res 11 (2005) 968-970
50. Valenti R., Huber V., Filipazzi P., et al. Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-β-mediated suppressive activity on T lymphocytes. Cancer Res 66 (2006) 9290-9298
51. Valenti R., Huber V., Iero M., et al. Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res 67 (2007) 2912-2915
52. Folkman J. Tumour angiogenesis: therapeutic implications. N Engl J Med 285 (1971) 1182-1186
53. Belting M., Ahamed J., and Ruf W. Signaling of the tissue factor coagulation pathway in angiogenesis and cancer. Arterioscler Thromb Vasc Biol 25 (2005) 1545-1550
54. Milsom C., Yu J., May L., et al. Diverse roles of tissue factor-expressing cell subsets in tumor progression. Semin Thromb Hemost 34 (2008) 170-181
55. Patry G., Hovington H., Larue H., et al. Tissue factor expression correlates with disease-specific survival in patients with node-negative muscle-invasive bladder cancer. Int J Cancer 122 (2008) 1592-1597
56. Pradier A., and Ettelaie C. The influence of exogenous tissue factor on the regulators of proliferation and apoptosis in endothelial cells. J Vasc Res 45 (2007) 19-32
57. Brill A., Dashevsky O., Rivo J., et al. Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc Res 67 (2005) 30-38
58. Mostefai H.A., Andriantsitohaina R., and Martínez M.C. Plasma membrane microparticles in angiogenesis: role in ischemic diseases and in cancer. Physiol Res 57 (2008) 311-320
59. Baj-Krzyworzeka M., Majka M., Pratico D., et al. Platelet-derived microparticles stimulate proliferation, survival, adhesion, and chemotaxis of hematopoietic cells. Exp Hematol 30 (2002) 450-459
60. Kim H.K., Song K.S., Chung J.H., et al. Platelet microparticles induce angiogenesis in vitro. Br J Haematol 124 (2004) 376-384
61. Janowska-Wieczorek A., Wysoczynski M., Kijowski J., et al. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer 113 (2005) 752-760
62. Janowska-Wieczorek A., Marquez-Curtis L.A., Wysoczynski M., et al. Enhancing effect of platelet-derived microvesicles on the invasive potential of breast cancer cells. Transfusion 46 (2006) 1199-1209
63. Taraboletti G., D'Ascenzo S., Borsotti P., et al. Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol 160 (2002) 673-680
64. Mezentsev A., Merks R.M., O'Riordan E., et al. Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress. Am J Physiol Heart Circ Physiol 289 (2005) H1106-H1114
65. Al-Nedawi K., Meehan B., Micallef J., et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol 10 (2008) 619-624
66. Millimaggi D., Mari M., D'Ascenzo S., et al. Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells. Neoplasia 9 (2007) 349-357
67. Janowska-Wieczorek A., Majka M., Kijowski J., et al. Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. Blood 98 (2001) 3143-3149
68. Liu B., Chen J.S., Cao M., et al. Platelet characteristic antigens of CD34+ cells in cryopreserved cord blood: a study of platelet-derived microparticles in transplant processing. Vox Sang 87 (2004) 96-104